Synlogic (STU:MIN) Tariff Resilience Score: 5/10 (As of Jul. 04, 2026)


STU:MIN Synlogic Inc STU:MIN
28 GF Score
Price €3.63
GF Value €0.16
! 1 Warning Sign
View Full Analysis

What is Synlogic Tariff Resilience Score?

Synlogic STU:MIN 28 Tariff Resilience Score is 5 as of Jul. 04, 2026. GuruFocus rates STU:MIN with a GF Score™ of 28/100 and a GF Value™ of €0.16. The stock has 1 warning sign investors should review. Among 1,373 Biotechnology companies, Synlogic ranks better than 62.27% on this metric.

Synlogic has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Synlogic has Biotech company with some exposure to tariffs on imported research materials. Limited historical impact but potential future risks. Mitigation through alternative suppliers and innovation.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Synlogic might have Average Resilient.

Synlogic  (STU:MIN) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Synlogic Tariff Resilience Score Related Terms

STU:MIN vs ASBP, PMCB, ERNA: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Synlogic's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synlogic Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synlogic's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Synlogic's Tariff Resilience Score falls into.


STU:MIN
28GF Score
Synlogic Inc STU:MIN
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Synlogic (STU:MIN) has a Tariff Resilience Score of 5 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Synlogic ranks #518 out of 1373 companies in the Biotechnology industry, placing it in the top 37.7%.
Is Synlogic's Tariff Resilience Score too high?
Synlogic's current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. Synlogic's value of 5 is 25% above this industry median. Based on the distribution chart, Synlogic ranks #518 out of 1373 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Synlogic has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Synlogic's Tariff Resilience Score compare to ASBP and PMCB?
According to the Biotechnology industry distribution chart, Synlogic ranks #518 out of 1373 companies for Tariff Resilience Score. This puts Synlogic in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Synlogic's value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,373 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synlogic's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synlogic's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synlogic stock overvalued right now?
Synlogic (STU:MIN) has a current Tariff Resilience Score of 5. The stock's GF Value™ is €0.16, compared to a current price of €3.63 — trading 2168.8% above its estimated fair value. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. Synlogic's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Synlogic (STU:MIN), the current Tariff Resilience Score is 5 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synlogic (STU:MIN) Overvalued in 2026?

Based on GuruFocus' analysis, Synlogic stock appears to be overvalued. The current stock price of €3.63 is trading 2168.8% above its estimated GF Value™ of €0.16.

Key valuation signals for STU:MIN:

  • Tariff Resilience Score: 5
  • GF Value™: €0.16 vs. price of €3.63 (2168.8% above fair value)
  • GF Score™: 28/100 with 1 warning sign
  • Industry Position: 25% above the Biotechnology median (#518 of 1373)

No single metric tells the full story. See the STU:MIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synlogic Business Description

Other Exchanges SYBX:USA0A8U:UK
Address PO Box 30, Winchester, MA, USA, 01890
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. The pipeline drug candidates includes: labafenogene marselecobac (SYNB1934); SYNB1353 Classical Homocystinuria (HCU); SYNB8802 Enteric Hyperoxaluria; and SYNB2081 Gout. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one operating segment: Discovery and development of Synthetic Biotics.
28GF Score

Get the complete analysis for STU:MIN

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.63
Price
€0.16
GF Value